Ovid Therapeutics Inc. Increase (Decrease) in Accounts Payable, Trade
Ovid Therapeutics Inc. (OVID) reported Increase (Decrease) in Accounts Payable, Trade of $2.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-13
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$1.51M, a 175.32% decline year-over-year.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $3.62M.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $246.00K, a 48.86% decline year-over-year.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$2.24M.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was -$1.23M.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was -$512.00K, a 129.26% decline from fiscal 2023.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was $1.75M.
- Ovid Therapeutics Inc. increase (decrease) in accounts payable, trade for fiscal 2022 was -$5.17M, a 403.91% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 3 month as first filed | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 6 month as first filed | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 9 month as first filed | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.12M 10-Q · filed 2026-08-13 | $2.36M derived: sum of 3 quarters · filed 2026-08-13 | $122.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $3.62M 10-Q · filed 2026-05-12 | $3.87M derived: sum of 2 quarters · filed 2026-05-12 | $1.63M derived: sum of 3 quarters · filed 2026-05-12 | $3.63M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$1.99M derived: sum of 2 quarters · filed 2026-03-18 | $8.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.23M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$238.00K derived: sum of 2 quarters · filed 2026-08-13 | -$1.48M 10-Q · filed 2025-11-12 | -$999.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $760.00K 10-Q · filed 2026-08-13 | $1.24M derived: sum of 3 quarters · filed 2026-08-13 | -$769.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$1.24M 10-Q · filed 2026-05-12 | -$761.00K derived: sum of 2 quarters · filed 2026-05-12 | -$2.77M derived: sum of 3 quarters · filed 2026-05-12 | -$1.65M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$1.53M derived: sum of 2 quarters · filed 2026-03-18 | -$405.00K derived: sum of 3 quarters · filed 2026-03-18 | -$512.00K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$886.00K derived: sum of 2 quarters · filed 2025-11-12 | -$993.00K 10-Q · filed 2025-11-12 | $1.49M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.02M 10-Q · filed 2025-08-13 | $3.50M derived: sum of 3 quarters · filed 2025-08-13 | $957.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$107.00K 10-Q · filed 2025-05-13 | $2.38M derived: sum of 2 quarters · filed 2025-05-13 | -$167.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.76M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$60.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.87M derived: sum of 3 quarters · filed 2025-03-11 | $1.75M 10-K · filed 2025-03-11 | $1.75M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$615.00K derived: sum of 2 quarters · filed 2024-11-12 | -$736.00K 10-Q · filed 2024-11-12 | -$736.35K 10-Q · filed 2023-11-03 | $183.84K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.81M 10-Q · filed 2024-08-13 | $1.81M 10-Q · filed 2023-08-04 | $2.73M derived: sum of 3 quarters · filed 2024-08-13 | -$853.63K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$121.00K 10-Q · filed 2024-05-14 | -$121.42K 10-Q · filed 2023-05-05 | $798.84K derived: sum of 2 quarters · filed 2024-05-14 | -$2.78M derived: sum of 3 quarters · filed 2024-05-14 | -$424.87K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $919.84K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$2.66M derived: sum of 2 quarters · filed 2024-03-08 | -$303.87K derived: sum of 3 quarters · filed 2024-03-08 | -$5.17M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | -$3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$1.22M derived: sum of 2 quarters · filed 2023-11-03 | -$6.09M 10-Q · filed 2023-11-03 | -$2.11M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$2.51M 10-Q · filed 2023-08-04 | $1.48M derived: sum of 3 quarters · filed 2023-08-04 | $3.71M derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2022-03-31 | -$4.87M 10-Q · filed 2023-05-05 | -$884.29K derived: sum of 2 quarters · filed 2023-05-05 | $1.35M derived: sum of 3 quarters · filed 2023-05-05 | -$890.44K derived: sum of 4 quarters · filed 2023-05-05 | ||||
| 2021-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $6.22M derived: sum of 2 quarters · filed 2023-03-13 | $3.98M derived: sum of 3 quarters · filed 2023-03-13 | $1.70M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$6.14K derived: sum of 2 quarters · filed 2022-11-08 | -$2.28M 10-Q · filed 2022-11-08 | $252.36K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$4.52M 10-Q · filed 2022-08-09 | -$1.98M derived: sum of 3 quarters · filed 2022-08-09 | -$3.72M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$2.28M 10-Q · filed 2022-05-10 | $258.50K derived: sum of 2 quarters · filed 2022-05-10 | -$1.48M derived: sum of 3 quarters · filed 2022-05-10 | -$875.62K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $798.20K derived: sum of 2 quarters · filed 2022-03-15 | $1.40M derived: sum of 3 quarters · filed 2022-03-15 | $2.33M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.13M derived: sum of 2 quarters · filed 2021-11-10 | -$202.12K 10-Q · filed 2021-11-10 | -$2.31M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $603.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.54M 10-Q · filed 2021-08-16 | -$573.59K derived: sum of 3 quarters · filed 2021-08-16 | $2.59M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $932.00K 10-Q · filed 2021-05-13 | -$1.18M derived: sum of 2 quarters · filed 2021-05-13 | $1.99M derived: sum of 3 quarters · filed 2021-05-13 | $13.99K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.05M derived: sum of 2 quarters · filed 2021-03-15 | -$918.01K derived: sum of 3 quarters · filed 2021-03-15 | -$653.95K 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.19M derived: sum of 2 quarters · filed 2020-11-13 | $1.46M 10-Q · filed 2020-11-13 | $591.27K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.71M 10-Q · filed 2020-08-10 | -$2.57M derived: sum of 3 quarters · filed 2020-08-10 | -$1.41M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $264.06K 10-Q · filed 2020-05-07 | -$599.83K derived: sum of 2 quarters · filed 2020-05-07 | $564.29K derived: sum of 3 quarters · filed 2020-05-07 | $1.55M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$863.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $300.23K derived: sum of 2 quarters · filed 2020-03-11 | $1.28M derived: sum of 3 quarters · filed 2020-03-11 | $1.65M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $2.15M derived: sum of 2 quarters · filed 2019-11-08 | $2.51M 10-Q · filed 2019-11-08 | $3.01M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $984.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.35M 10-Q · filed 2019-08-07 | $1.84M derived: sum of 3 quarters · filed 2019-08-07 | -$138.22K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $365.45K 10-Q · filed 2019-05-07 | $860.61K derived: sum of 2 quarters · filed 2019-05-07 | -$1.12M derived: sum of 3 quarters · filed 2019-05-07 | $723.05K derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $495.16K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$1.49M derived: sum of 2 quarters · filed 2019-03-07 | $357.60K derived: sum of 3 quarters · filed 2019-03-07 | $1.08M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$137.56K derived: sum of 2 quarters · filed 2018-11-08 | $581.19K 10-Q · filed 2018-11-08 | $920.11K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.56M 10-Q · filed 2018-08-09 | $2.90M derived: sum of 3 quarters · filed 2018-08-09 | $2.45M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $718.75K 10-Q · filed 2018-05-08 | $1.06M derived: sum of 2 quarters · filed 2018-05-08 | $606.48K derived: sum of 3 quarters · filed 2018-05-08 | $756.29K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $338.92K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$112.27K derived: sum of 2 quarters · filed 2018-03-29 | $37.54K derived: sum of 3 quarters · filed 2018-03-29 | $186.62K 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | -$451.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$301.38K derived: sum of 2 quarters · filed 2017-11-09 | -$152.30K 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $149.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $298.90K 10-Q · filed 2017-08-10 | ||||||
| 2016-03-31 | $149.08K 10-Q · filed 2017-06-13 | |||||||
| 2015-12-31 | $591.41K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |